Cara Therapeutics
CARA
$0.67
Share price
-5.02%
Change (1 day)
-83.21%
Change (1 year)
Categories
EPS for Cara Therapeutics (CARA)
EPS in 2023 (TTM): -$2.06
According to Cara Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.06. In 2022 the company made an earnings per share (EPS) of -$1.59 an increase over its 2021 EPS that were of -$1.73.
EPS history for Cara Therapeutics from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.06 | 29.56% |
| 2022 | -$1.59 | -8.09% |
| 2021 | -$1.73 | -1061.11% |
| 2020 | $0.18 | -107.23% |
| 2019 | -$2.49 | 20.87% |
| 2018 | -$2.06 | 7.85% |
| 2017 | -$1.91 | -9.05% |
| 2016 | -$2.10 | 110% |
| 2015 | -$1.00 | 17.65% |
| 2014 | -$0.85 | -3.42% |
| 2013 | -$0.88 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -783.75% | 🇺🇸 USA |
 Pfizer PFE | $1.86 | -190.29% | 🇺🇸 USA |
 Trevena TRVN | -$4.48 | 117.48% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$9.78 | 374.64% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | -$3.09 | 50.00% | 🇺🇸 USA |